Recombinant CD276 (Ifinatamab Biosimilar) anticorps

N° du produit ABIN7795144

Cet anticorps anti-CD276 (Ifinatamab Biosimilar) Monoclonal Humanized (ABIN7795144) détecte spécifiquement CD276 (Ifinatamab Biosimilar) dans FACS et in vivo. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant CD276 (Ifinatamab Biosimilar) anticorps (ABIN7795144)

Antigène: CD276 (Ifinatamab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD276 (Ifinatamab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-CD276 (Ifinatamab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Ifinatamab Biosimilar, Human B7-H3 Monoclonal Antibody

Attributs du produit: What is ifinatamab biosimilar research grade? Ifinatamab is a humanized IgG1-kappa monoclonal antibody against the human B7-H3 (CD276) protein, a type I transmembrane protein belonging to the B7 family which includes immune checkpoint molecules CTLA-4 and PD-L1. B7-H3 is highly expressed in various types of solid tumors with low expression in normal (healthy) tissues. It was reported that B7-H3 overexpression is associated with poor prognosis in several types of cancers. Ifinatamab biosimilar uses the same protein sequences as the therapeutic antibody ifinatamab.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human B7-H3

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur CD276 (Ifinatamab Biosimilar)

Antigène: CD276 (Ifinatamab Biosimilar)

Autre désignation: Ifinatamab Biosimilar

Classe de substances: Biosimilar